PSMD1: A Potential Drug Target and Biomarker for Proteasome-Mediated Diseases

Target Name: PSMD1

NCBI ID: G5707

PSMD1

PSMD1: A Potential Drug Target and Biomarker for Proteasome-Mediated Diseases

Proteasomes, also known as intracellular granules, are key protein structures that play a crucial role in regulating various cellular processes. They are responsible for breaking down and processing foreign particles, as well as maintaining the cytoskeleton and organizing organelles within the cell. The 26S subunit of the proteasome, which is composed of the protein PSMD1, has been identified as a potential drug target and biomarker for several proteasome-mediated diseases.

PSMD1: Structure and Function

PSMD1 is a non-ATPase protein that belongs to the Peptide-Protein Ligation Enzyme (PPL) family. It has a molecular weight of approximately 18 kDa and a pre-steady-state nitrogen atom content of 11.5%. PSMD1 is expressed in various cell types, including human tissues, and its localization is primarily to the cytoplasm.

PSMD1 functions as a key component of the proteasome complex. It is responsible for catalyzing the ligation of peptides from the precursor protein onto the 26S subunit of the proteasome. This process is critical for the efficient degradation of foreign particles, such as viruses and other microbial agents, as well as for maintaining cellular homeostasis.

PSMD1 is also involved in the regulation of protein interactions within the proteasome complex. Studies have shown that PSMD1 can interact with several other proteins, including the 26S subunit of the proteasome, the transcription factor PAX-POM1, and the protein NEDD8. These interactions may play a role in regulating the activity and stability of the proteasome and its subunits.

PSMD1 as a Drug Target

The potential drug targeting of PSMD1 is based on its involvement in the regulation of the proteasome complex. Several studies have shown that inhibitors of PSMD1 can significantly reduce the activity of the proteasome, leading to the degradation of foreign particles and the disruption of cellular homeostasis.

One of the most promising strategies for targeting PSMD1 is the use of small molecules that can inhibit the activity of the enzyme. Many of these molecules have been identified as potential drug candidates, including inhibitors of the protein kinase CK-ATPase, which is a known activator of PSMD1.

PSMD1 as a Biomarker

PSMD1 can also be used as a biomarker for several proteasome-mediated diseases. The degradation of foreign particles by PSMD1 is often accompanied by the formation of inclusion bodies, which can be visualized using techniques such as affinity purification and immunofluorescence.

In addition, the levels of PSMD1 and its associated protein interactions, such as those with the transcription factor PAX-POM1, can be used as biomarkers for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Conclusion

PSMD1 is a non-ATPase protein that plays a critical role in the regulation of the proteasome complex. Its involvement in the degradation of foreign particles and the maintenance of cellular homeostasis makes it an attractive target for drug development. Furthermore, its role as a biomarker for several proteasome-mediated diseases makes it an important tool for the diagnosis and treatment of these conditions.

While more research is needed to fully understand the mechanisms of PSMD1 and its potential as a drug target and biomarker, its identification and characterization as a promising drug candidate and biomarker open up new avenues for the development of new treatments for a variety of diseases.

Protein Name: Proteasome 26S Subunit, Non-ATPase 1

Functions: Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair

The "PSMD1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PSMD1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets